title: Towards a safe and effective chlamydial vaccine: lessons from the eye.
abstract: As well as being the most common bacterial sexually transmitted infection, Chlamydia trachomatis (Ct) is the leading infectious cause of blindness. The pathogenesis of ocular chlamydial infection (trachoma) is similar to that of genital infection. In the 1960s the efficacy of Ct vaccines against ocular infection was evaluated in major field trials in Saudi Arabia, Taiwan, The Gambia, India and Ethiopia. These trials showed that it was possible to induce short term immunity to ocular infection, and to reduce the incidence of inflammatory trachoma, by parenteral immunisation with killed or live whole organism vaccines. In one study, it was also shown that the incidence of scarring sequelae was reduced in vaccinated children. Detailed studies in non-human primates conducted at this time suggested that vaccination could lead to more severe inflammatory disease on subsequent challenge. Since that time there have been many studies on the immunological correlates of protective immunity and immunopathology in ocular Ct infection in humans and non-human primates, and on host genetic polymorphisms associated with protection from adverse sequelae. These have provided important information to guide the development and evaluation of a human Ct vaccine.
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, United Kingdom. Electronic address: david.mabey@lshtm.ac.uk.
authors.forename: David C W
authors.initials: DC
authors.lastname: Mabey
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, United Kingdom.
authors.forename: Victor
authors.initials: V
authors.lastname: Hu
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, United Kingdom.
authors.forename: Robin L
authors.initials: RL
authors.lastname: Bailey
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, United Kingdom.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Burton
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, United Kingdom.
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Holland
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D001766:Blindness / Q000382:microbiology / Q000517:prevention & control; D002692:Chlamydia trachomatis / Q000145:classification; D002986:Clinical Trials as Topic; D005123:Eye / Q000382:microbiology / Q000473:pathology; D006801:Humans; D014141:Trachoma / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D014611:Vaccination / Q000639:trends
chemical_list: D001428:Bacterial Vaccines
keywords: Chlamydia; Immunopathology; Protective immunity; Trachoma; Vaccine